Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Cox Media Group Names SVP & Chief Sales Officer – CMG Television
-
Bayer to Present New Prespecified Subgroup Analyses from Investigational Phase III FINEARTS-HF Trial in Patients with Heart Failure with LVEF ≥40% at AHA 2024
-
United Community Banks, Inc. Announces Quarterly Cash Dividend on Common and Preferred Stock
-
Cox Media Group Names SVP & Chief Sales Officer – CMG Television
-
CNH Brands Case IH and STEYR Win EIMA 2025 Tractor of the Year Awards
-
Nature's Miracle Holding Inc. Announces Third Quarter 2024 Financial Results
-
Talon Metals Reports Results for the Quarter Ended September 30, 2024
-
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
-
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information
-
QuoteMedia Announces Financial Results for Q3 2024
-
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Third Quarter 2024 Financial Results
-
Cabana Partners with Virginia Department of Veterans Services to Provide Comprehensive, Free Mental Health Support for Veterans, Guard/Reserve Members, and Their Families
-
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
-
NASA Johnson Invites Proposals to Lease Vibration Test Facility
-
The New Home Company Schedules Earnings Conference Call for the Fiscal 2024 Fourth Quarter
-
Kadant Declares Cash Dividend
-
Fusion CBD Products Launches Wiggles & Paws
-
Precision Optics Receives Initial Production Order for Single-Use Ophthalmic Program
-
Evolv Technologies (EVLV) Delays Filing Quarterly Report After Previously Admitting to Improper Revenue Recognition - Hagens Berman
-
Edwards Lifesciences (EW) Faces Investor Class Action Over Loss of $16 Billion of Market Capitalization - Hagens Berman
-
NASA, Peru Agree to Study Potential Sounding Rocket Campaign
-
Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)
-
Santa Cruz County Bank Announces Retirement of Mary Anne Carson, EVP, Chief Marketing Officer
-
Precision Optics Reports First Quarter Fiscal Year 2025 Financial Results
-
METALLA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2024 AND PROVIDES ASSET UPDATES
-
Precigen Reports Third Quarter 2024 Financial Results and Business Updates
-
POET Technologies Reports Third Quarter 2024 Financial Results
-
Jewett-Cameron to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on November 20, 2024
-
MDU Resources Welcomes Vernon Dosch to Board of Directors
-
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
-
BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
-
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update
-
Introducing the Smart AEI Tag: Revolutionizing Railcar Tracking with Real-Time Data and Enhanced Connectivity for the Perfect Rail Ecosystem
-
Docebo Announces Participation in Upcoming Investor Conferences in November and December
-
CACI Earns 11 Prestigious Awards in 2024 as a Recognized Leader in Veteran Hiring and Inclusivity
-
Auddia to Present at the Virtual Investor Summit Microcap Event on November 21st
-
PEDEVCO Announces Q3 2024 Financial Results and Operations Update
-
MaxLinear Announces New Employee Inducement Grants
-
Floor & Decor Announces Grand Opening of Georgetown, Texas Store
-
The Metals Company Announces US$17.5 Million Registered Direct Offering of Common Shares and Class B Warrants
-
Fusion CBD Products Launches Wiggles & Paws
-
Britannia Life Sciences Inc. Announces Results of Annual Meeting of Shareholders
-
XWELL, Inc. Reports Third Quarter 2024 Results
-
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Wi2Wi Corporation Announces Private Placement
-
Wilton Resources Inc. Announces Grant of Stock Options
-
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
-
NRG Energy Honors Business Customers During Fifth Annual Excellence in Energy Awards
-
Sidus Space Announces Closing of $7.0 Million Public Offering
-
Campbell’s Appoints Daniel L. Poland Chief Enterprise Transformation Officer

